Motley Fool Australia

Paradigm Biopharmaceuticals Ltd (ASX: PAR) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Paradigm Biopharmaceuticals Ltd (ASX: PAR) Latest News

medical asx share price represented by doctor giving thumbs up

Why the Paradigm (ASX:PAR) share price is jumping higher

More »

Red and white arrows showing share price drop

Why Mesoblast, Paradigm, Qantas, & QBE shares are tumbling lower

More »

shares valuation higher upgrade, growth shares

Why the Paradigm (ASX:PAR) share price is pushing higher today

More »

shares lower

Paradigm (ASX:PAR) share price drops lower on trial update

More »

row of piggy banks with large one receiving injection representing rising Immutep share price

Why the Paradigm (ASX:PAR) share price is climbing higher today

More »

Why BHP, Paradigm, Reliance, & SeaLink shares are charging higher today

More »

Digitised heart rate and share price chart with man on ipad in background signifying share price

Paradigm (ASX:PAR) share price rockets higher on Zilosul update

More »

man jumps up a chart, indicating share price going up on the ASX bank dividend

Why Flight Centre, MoneyMe, Paradigm, & Zip shares are pushing higher today

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
19 Nov 2020 Christopher Fullerton Transfer 1 $3,050,000
19 Nov 2020 Christopher Fullerton Transfer 1 $3,050,000
19 Nov 2020 Paul Rennie Buy 600 $1,830,000
19 Nov 2020 Donna Skerrett Buy 500 $1,525,000
11 May 2020 John Gaffney Sell 115 $274,118
08 May 2020 Paul Rennie Sell 4 $9,502,606
08 May 2020 Graeme Kaufman Sell 184 $423,697
13 Mar 2020 Paul Rennie Buy 28 $49,786
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr Paul Rennie Chief Executive Officer,Managing Director,Interim Chairman May 2014
Mr Amos Meltzer Non-Executive Director Dec 2020
Mr John Gaffney Non-Executive Director Sep 2014
Dr Donna Skerrett Executive Director Jul 2020
Mr Kevin G Hollingsworth Company Secretary
Kevin G Hollingsworth Company Secretary

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 13,293,732 5.86%
Kzee Pty Ltd <Kzee Superannuation Fund A/C> 10,781,467 4.75%
J P Morgan Nominees Australia Pty Limited 7,966,450 3.51%
Paul John Rennie 7,630,400 3.36%
CS Third Nominees Pty Limited <Hsbc Cust Nom Au Ltd 13 A/C> 5,106,723 2.25%
Citicorp Nominees Pty Limited 5,010,176 2.21%
Nancy Edith Wilson-Ghosh <Ghosh Family A/C> 3,860,835 1.70%
MJGD Nominees Pty Ltd <Bsmi A/C> 2,768,232 1.22%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 2,700,323 1.19%
V Redford Pty Ltd <Redford S/F A/C> 2,505,419 1.10%
Mr Evan Philip Clucas + Ms Leanne Jane Weston <Kuranga Nursery Super A/C> 2,427,913 1.07%
Mr Brett Langan 2,403,432 1.06%
JGM Investment Group Pty Ltd <Muchnicki Family A/C> 2,185,715 0.96%
Sandhurst Trustees Ltd <Collins St Value Fund A/C> 2,177,947 0.96%
Himstedt & Co Pty Ltd <The Himstedt Family A/C> 1,921,871 0.85%
BNP Paribas Noms Pty Ltd <Drp> 1,820,100 0.80%
Irwin Biotech Nominees Pty Ltd <Bioa A/C> 1,802,490 0.79%
View 26 Pty Ltd <View 26 A/C> 1,650,000 0.73%
Ms Lenna Yu Ling Tye 1,521,631 0.67%
Australian Executor Trustees Limited <No 1 Account> 1,492,100 0.66%
Show more